Diagnostic colonoscopy completion after abnormal fecal immunochemical testing and quality of tests used at 8 Federally Qualified Health Centers in Southern California: Opportunities for improving screening outcomes

The effectiveness of colorectal cancer screening with fecal immunochemical tests (FITs) of stool blood depends on high rates of colonoscopy follow‐up for abnormal FITs and the use of high‐quality tests. This study characterized colonoscopy referral and completion among patients with abnormal FITs and the types of FITs implemented in a sample of Southern California Federally Qualified Health Centers (FQHCs).

[1]  S. Fedewa,et al.  Colorectal cancer screening in the United States: Trends from 2008 to 2015 and variation by health insurance coverage. , 2018, Preventive medicine.

[2]  A. Zauber,et al.  A Comparison of Fecal Immunochemical and High-Sensitivity Guaiac Tests for Colorectal Cancer Screening , 2017, The American Journal of Gastroenterology.

[3]  Christopher D. Jensen,et al.  Interventions to Improve Follow-up of Positive Results on Fecal Blood Tests , 2017, Annals of Internal Medicine.

[4]  R. Wong,et al.  The Need for an Integrated Patient Navigation Pathway to Improve Access to Colonoscopy After Positive Fecal Immunochemical Testing: A Safety-Net Hospital Experience , 2017, Journal of Community Health.

[5]  R. Beyth,et al.  Barriers and facilitators associated with colonoscopy completion in individuals with multiple chronic conditions: a qualitative study , 2017, Patient preference and adherence.

[6]  J. Nayor,et al.  Appointment-keeping behaviors and procedure day are associated with colonoscopy attendance in a patient navigator population. , 2017, Preventive medicine.

[7]  D. Lieberman,et al.  Recommendations on Fecal Immunochemical Testing to Screen for Colorectal Neoplasia: A Consensus Statement by the US Multi-Society Task Force on Colorectal Cancer. , 2017, Gastroenterology.

[8]  S. Chiou,et al.  Association Between Colorectal Cancer Mortality and Gradient Fecal Hemoglobin Concentration in Colonoscopy Noncompliers , 2017, Journal of the National Cancer Institute.

[9]  U. Sarkar,et al.  Inadequate Utilization of Diagnostic Colonoscopy Following Abnormal FIT Results in an Integrated Safety-Net System , 2017, The American Journal of Gastroenterology.

[10]  Stephen Taplin,et al.  Implementation successes and challenges in participating in a pragmatic study to improve colon cancer screening: perspectives of health center leaders , 2017, Translational behavioral medicine.

[11]  E. Conant,et al.  Follow-Up of Abnormal Breast and Colorectal Cancer Screening by Race/Ethnicity. , 2016, American journal of preventive medicine.

[12]  M. Kochman,et al.  Colorectal Cancer Screening Navigation for the Underserved: Experience of an Urban Program. , 2016, Gastroenterology & hepatology.

[13]  Karen M Kuntz,et al.  Estimation of Benefits, Burden, and Harms of Colorectal Cancer Screening Strategies: Modeling Study for the US Preventive Services Task Force. , 2016, JAMA.

[14]  M. Phipps,et al.  Screening for Colorectal Cancer: US Preventive Services Task Force Recommendation Statement. , 2016, JAMA.

[15]  Amanda F. Petrik,et al.  Timeliness of Colonoscopy After Abnormal Fecal Test Results in a Safety Net Practice , 2016, Journal of Community Health.

[16]  C. Sieck,et al.  The Challenge of Improving Breast Cancer Care Coordination in Safety-net Hospitals: Barriers, Facilitators, and Opportunities , 2016, Medical care.

[17]  D. Ransohoff,et al.  Multitarget stool DNA testing for colorectal-cancer screening. , 2014, The New England journal of medicine.

[18]  B. Thompson,et al.  Cancer Screening at a Federally Qualified Health Center: A Qualitative Study on Organizational Challenges in the Era of the Patient-Centered Medical Home , 2013, Journal of Immigrant and Minority Health.

[19]  Chyke A Doubeni,et al.  Screening Colonoscopy and Risk for Incident Late-Stage Colorectal Cancer Diagnosis in Average-Risk Adults , 2013, Annals of Internal Medicine.

[20]  B. Hemmelgarn,et al.  Prevalence of adenomas and colorectal cancer in average risk individuals: a systematic review and meta-analysis. , 2009, Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association.

[21]  M. Wolf,et al.  Improving Colorectal Cancer Screening Among the Medically Underserved: A Pilot Study within a Federally Qualified Health Center , 2007, Journal of General Internal Medicine.

[22]  D. Lieberman,et al.  Recommendations on Fecal Immunochemical Testing to Screen for Colorectal Neoplasia: A Consensus Statement by the US Multi-Society Task Force on Colorectal Cancer , 2017, The American Journal of Gastroenterology.

[23]  Jasmin A. Tiro,et al.  Reasons for Lack of Diagnostic Colonoscopy After Positive Result on Fecal Immunochemical Test in a Safety-Net Health System. , 2017, The American journal of medicine.